Get the Stockscreener App
28.76
0.88%
0.25
After Hours:
28.95
0.19
+0.66%
Caredx Inc stock is traded at $28.76, with a volume of 560.96K.
It is up +0.88% in the last 24 hours and up +25.21% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$28.51
Open:
$27.95
24h Volume:
560.96K
Relative Volume:
0.68
Market Cap:
$1.49B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-186.63
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
-1.03%
1M Performance:
+25.21%
6M Performance:
+42.45%
1Y Performance:
+42.87%
1-Day Range:
$27.68
$28.80
1-Week Range:
$27.32
$29.43
52-Week Range:
$10.96
$30.00
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
28.76 | 1.47B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
528.51 | 195.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.16 | 140.88B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.21 | 44.46B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
272.89 | 38.66B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
134.04 | 37.93B | 7.23B | 1.41B | 1.09B | 4.979 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
How Caredx Inc. (CDNA) Affects Rotational Strategy Timing - Stock Traders Daily
Price to earnings forward of CareDx, Inc. – LSX:A118WG - TradingView
CareDx to Participate in Upcoming Investor Conferences - AOL.com
Form 4 Caredx Inc For: 7 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) director receives 1,746-share quarterly stock grant as compensation - Stock Titan
CareDx (CDNA) exits lab products and acquires Naveris to expand $12B market - Stock Titan
CareDx Completes Naveris Acquisition and Expands Oncology Reach - Yahoo Finance
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics Compounder (CDNA) - Seeking Alpha
Diagnostic Co.'s Oversight Reforms Deal Gets Final OK - Law360
Form 4 Caredx Inc For: 6 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) CEO has 8,511 shares withheld for RSU tax obligations - Stock Titan
CareDx Leaders’ Audit Reforms Settlement Gets Court Approval (1) - Bloomberg Law News
CareDx Deadline Alert - TMX Newsfile
Enterprise value to EBITDA forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
CareDx Inc (CDNA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CDNACaredx Inc Short Interest - Finviz
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology - Yahoo Finance
CareDx Inc. (CDNA) Holds Steady Near Resistance as Consolidation ContinuesSystematic Flow - dars.gov.et
CareDx (CDNA) general counsel has 997 shares withheld for tax obligations - Stock Titan
CareDx (CDNA) CCO has shares withheld to cover taxes on RSU vesting - Stock Titan
CareDx (CDNA) CFO & COO reports RSU tax withholding, holds 219,924 shares - Stock Titan
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division - Clinical Lab Products
(CDNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology - BioSpace
CareDx Completes Acquisition of Naveris, Extending Leadership in - GuruFocus
CareDx completes acquisition of Naveris - Investing.com
CareDx completes acquisition of Naveris By Investing.com - Investing.com Canada
Eurobio Scientific closes an acquisition - marketscreener.com
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division - GlobeNewswire
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific - BioSpace
CareDx president and CEO John Hanna sells $1.17m stock By Investing.com - Investing.com South Africa
CareDx completes sale of lab products unit for $171.2M - Investing.com UK
CareDx, Inc. completed the acquisition of Naveris, Inc. from B-Flexion Advisors (UK) LLP. - marketscreener.com
CareDx president and CEO John Hanna sells $1.17m stock - Investing.com
Form 4 Caredx Inc For: 30 June By Investing.com - Investing.com India
CareDx (CDNA) CEO exercises 70k options, sells 40k shares under 10b5-1 plan - Stock Titan
CareDx completes sale of lab products unit for $171.2M By Investing.com - Investing.com Nigeria
CareDx Closes Sale of Lab Products Business to Eurobio Scientific - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - The National Law Review
Eurobio Scientific Société anonyme completed the acquisition of Caredx AB and Kitted Laboratory Products Business and Related Software of CareDx, Inc.. - marketscreener.com
CDNA: Insider Form 144 to sell 39,500 shares after option exercise (06/29/2026) - Stock Titan
Enterprise value to EBIT forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
Caredx Inc stock hits 52-week high at $29.08 - Investing.com
Caredx Inc stock hits 52-week high at $29.08 By Investing.com - Investing.com Nigeria
Supreme Court Declines to Hear CareDx Appeal in Natera False-Advertising CaseHealthcare Earnings Report - dars.gov.et
1K9 Forecast — Price Target — Prediction for 2027 - TradingView
Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (CDNA) and Medtronic (MDT) - The Globe and Mail
Price to sales forward of CareDx, Inc. – BOATS:CDNA - TradingView
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hanna John Walter JR | President and CEO |
Jun 15 '26 |
Option Exercise |
8.20 |
15,676 |
128,543 |
661,959 |
| Hanna John Walter JR | President and CEO |
Jun 11 '26 |
Option Exercise |
8.20 |
13,618 |
111,668 |
646,283 |
| Hanna John Walter JR | President and CEO |
Jun 04 '26 |
Option Exercise |
8.20 |
706 |
5,789 |
632,665 |
| Hanna John Walter JR | President and CEO |
Jun 26 '26 |
Option Exercise |
8.20 |
100 |
820 |
662,059 |
| Hanna John Walter JR | President and CEO |
Jun 29 '26 |
Sale |
29.24 |
39,900 |
1,166,836 |
661,959 |
| Hanna John Walter JR | President and CEO |
Jun 26 '26 |
Sale |
29.00 |
100 |
2,900 |
661,959 |
0.04%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):